It is an SSRI, but it also acts as an antagonist of the 5-HT3, 5-HT7, and 5-HT1D receptor, and a partial 5-HT1B and 5-HT1A agonist, reducing the exacerbated expression of the fear memory associated with anxiety and depressive disorders [35]. This evidence concerns the gene HTR7 and depressive disorder.